Chugai Pharmabody Research
Innovation beyond Imagination
Innovation beyond Imagination
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.
There is no investment information
No recent news or press coverage available for Chugai Pharmabody Research.
We care about your data, and we'd love to use cookies make your experience better.
